Chinese herbal medicines used in pregnancy: A population-based survey in Taiwan

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 4, 2007, Pages 464-468

  Chuang, Chao Hua ^a,b   Hsieh, Wu Shiun ^c   Guo, Yueliang Leon ^c   Tsai, Yih Jian ^d   Chang, Pei Jen ^e   Lin, Shio Jean ^f   Chen, Pau Chung ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b FOOYIN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d DEPARTMENT OF HEALTH   (Taiwan)

^e NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

^f NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Chinese herbal medicine; Pregnant women; Prevalence rate; Related factors; Threatened abortion

Indexed keywords

AN TAI YIN; ANGELICA EXTRACT; ANGELICA SINENSIS EXTRACT; ARTEMISIA ARGYI EXTRACT; ASTRAGALUS EXTRACT; CHINESE DRUG; CITRUS IMMATURUS EXTRACT; COPTIS CHINENSIS EXTRACT; COPTIS RHIZOME; CUSCUTA EXTRACT; FRITILLARIA BULBUS EXTRACT; GINGER EXTRACT; GINSENG EXTRACT; GLYCYRRHIZA EXTRACT; HERBACEOUS AGENT; LIGUSTICUM CHUANXIONG EXTRACT; LIGUSTICUM EXTRACT; MAGNOLIACEAE EXTRACT; MARGARITA EXTRACT; NOTOPTERYGUM EXTRACT; PAEONIA EXTRACT; PAEONIA LACTIFLORA EXTRACT; PLANT EXTRACT; REHMANNIA EXTRACT; SCHIZONEPETA EXTRACT; SZU WU TANG; UNCLASSIFIED DRUG;

ADULT; ARTEMISIA; ARTEMISIA ARGYI; ARTICLE; CITRUS IMMATURUS; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; FEMALE; FRITILLARIA; FRITILLARIA BULBUS; HEALTH SURVEY; HUMAN; IMMINENT ABORTION; INTERVIEW; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MARGARITA; MEDICINAL PLANT; NOTOPTERYGUM; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; QUESTIONNAIRE; REGISTER; RISK FACTOR; SCHIZONEPETA; TAIWAN;

ABORTION, THREATENED; ADULT; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; LONGITUDINAL STUDIES; PILOT PROJECTS; POPULATION SURVEILLANCE; PREGNANCY; PROSPECTIVE STUDIES; QUESTIONNAIRES; REGISTRIES; REPRODUCIBILITY OF RESULTS; TAIWAN;

EID: 34247525033     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1332     Document Type: Article

References (9)

1. Nordeng H, Havnen GC. Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepidemiol Drug Saf 2004; 13: 371-380.
2. Chuang CH, Lai JN, Wang JD, Chang PJ, Chen PC. Prevalence and Related Factors of Chinese Herbal Medicine Use in Pregnant Women of Taipei, 1985-1987. Taiwan J Public Health 2005; 24: 335-347.
3. Gibson PS, Powrie R, Star J. Herbal and alternative medicine use during pregnancy: a cross-sectional survey. Obstet Gynecol 2001; 97(Suppl): S44-S45.
4. Vutyavanich T, Kraisarin T, RuangsTi R-A. Ginger for nausea and vomiting in pregnancy: a randomised, double-masked, placebo-controlled trial. Obstet Gynecol 2001; 97: 577-582.
5. Chuang CH, Lai JN, Wang JD, Chang PJ, Chen PC. Use of Coptidis Rhizoma and foetal growth - A follow-up study of 9,895 pregnancies. Pharmacoepidemiol Drug Saf 2006; 15: 185-192.
6. Chuang CH, Doyle P, Wang JD, Chang PJ, Lai JN, Chen PC. Herbal medicines used during the first trimester and major congenital malformations - An analysis of data from a pregnancy cohort study. Drug Saf 2006; 29: 537-548.
7. Price CJ, George JD, Marr MC, Myers CB, Jahnke GD. Developmental toxicity evaluation of berberine chloride dehydrate (BCD) in Sprague-Dawley (CD) rats. Teratology 2001; 63: 279.
8. Chan LY, Chiu PY, Lau TK. An in-vitro study of ginsenoside Rb1-induced teratogenicity using a whole rat embryo culture model. Hum Reprod 2003; 18: 2166-2168.
9. Chuang CH, Chang PJ, Hsieh WS, Guo YL, Lin SH, Lin SJ, Chen PC. A combined effect of employment status and trans-cultural marriage on breast feeding: a population-based survey in Taiwan. Paediatr Perinat Epidemiol 2006; 20: (in press).